Royalty Pharma plc (RPRX)
NASDAQ: RPRX · Real-Time Price · USD
37.11
+0.44 (1.20%)
Oct 30, 2025, 11:38 AM EDT - Market open
Royalty Pharma Market Cap
Royalty Pharma has a market cap or net worth of $21.64 billion as of October 30, 2025. Its market cap has increased by 72.35% in one year.
Market Cap
21.64B
Enterprise Value
28.94B
1-Year Change
72.35%
Ranking
Category
Stock Price
$37.11
Market Cap Chart
Since June 16, 2020, Royalty Pharma's market cap has increased from $15.76B to $21.64B, an increase of 37.31%. That is a compound annual growth rate of 6.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2025 | 15.74B | 38.87% |
| Dec 31, 2024 | 11.33B | -9.30% |
| Dec 29, 2023 | 12.50B | -28.31% |
| Dec 30, 2022 | 17.43B | 1.85% |
| Dec 31, 2021 | 17.12B | -11.89% |
| Dec 31, 2020 | 19.43B | 23.26% |
| Jun 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 736.23B |
| Johnson & Johnson | 449.42B |
| AbbVie | 401.96B |
| UnitedHealth Group | 333.14B |
| AstraZeneca | 255.54B |
| Novartis AG | 239.27B |
| Novo Nordisk | 229.86B |
| Abbott Laboratories | 220.36B |